Frank D. Lee
CIK 1814686 · Chief Executive Officer · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.67M
Companies
4
Total Filings
22
Lifetime Open-Market Net
-$330.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHC | Director | 95,210 | $5.06 | $481.8K | -$254.7K | 5 | 2026-05-26 |
| PCRX | Chief Executive Officer | 660,830 | $22.99 | $15.19M | $100.0K | 7 | 2026-02-13 |
| BOLT | Director | — | $4.56 | — | $0 | 5 | 2024-06-14 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | President and CEO | 0 | $20.01 | $0 | -$175.8K | 5 | 2022-10-14 |
Recent Filings · Page 3 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-02 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | +97,750 | $0 | EDGAR |
| 2020-06-22 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–22 of 22
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.